I will say, that if they go current and there is no buyout within say a month, then I hope the company moves forward with clinical trials. The worst thing that could happen is that they go current, there is no buyout or partnership, then we get silence for months. That would be a killer. They need to start moving forward without any procrastination. This bear market will not tolerate companies that aren't moving forward at 100 mph.
Market Data 
Markets 
AI
